Perrigo | PRGO - Assets


Perrigo reported $8.54B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Abbott USD 86.71B 2.53B Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Coherus Biosciences USD 258.34M 258.18M Dec/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Dr.Reddys Laboratories INR 562.9B 20.89B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
J&J USD 200.89B 1.68B Mar/2026
Merck USD 129.55B 12.02B Sep/2025
Nestle CHF 127.15B 2.97B Dec/2025
Pacira USD 1.26B 32.66M Dec/2025
Perrigo USD 8.54B 1.55B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Phibro Animal Health USD 1.41B 20.03M Dec/2025
Prestige Brands USD 3.49B 52.46M Dec/2025
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
Sanofi EUR 128.02B 1.22B Mar/2026
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025
Zoetis USD 15.47B 308M Dec/2025